Related Experiment Video
Updated: Aug 5, 2026
11:56
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Dual-Mechanism Antimicrobial Peptides from a Nature-Inspired Scaffold
Luisa I Beyer1,2,3, Johannes Thoma1,3, Silvana Lord Smits1,3
1University of Gothenburg, Department of Chemistry and Molecular Biology, Medicinaregatan 16, Gothenburg 413 90, Sweden.
Journal of Medicinal Chemistry
|July 27, 2026
Summary
Researchers developed new antimicrobial peptides that are more potent than existing antibiotics. These peptides inhibit bacterial protein expression, offering a novel strategy against drug-resistant pathogens.
Area of Science:
- Biochemistry
- Microbiology
- Drug Discovery
Background:
- Antimicrobial peptides (AMPs) show promise as alternatives to conventional antibiotics.
- Limited strategies exist for enhancing AMP potency and understanding their mechanisms.
- Developing novel antimicrobial agents is crucial due to rising antibiotic resistance.
Purpose of the Study:
- To generate and evaluate a focused library of antimicrobial peptides derived from a lead peptide (L3).
- To identify peptide variants with enhanced antimicrobial activity against clinically relevant pathogens.
- To elucidate the mechanism of action of potent antimicrobial peptide variants.
Main Methods:
- Systematic generation of 20 peptide variants from the lead peptide L3.
- Antimicrobial activity testing against pathogens like Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Candida albicans.
- Mechanistic studies including membrane-lytic activity assays and in vitro transcription/translation inhibition assays.
Main Results:
- Several peptide variants demonstrated enhanced antibacterial activity, with minimum inhibitory concentrations (MICs) as low as 32 μg/mL.
- Specific variants (G1-8, G2-1, G2-2, G2-10) achieved MICs of 64 μg/mL against E. coli.
- Mechanistic studies indicated that peptide variants primarily inhibit protein expression rather than causing significant membrane lysis.
Conclusions:
- Targeted sequence refinement of antimicrobial peptides can significantly enhance their potency.
- The primary mechanism of action for these enhanced peptides involves inhibition of protein expression.
- These findings offer a promising avenue for developing novel antimicrobial therapies against resistant bacteria.
Related Concept Videos
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...